Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Genentech, Inc.
Keythera (Suzhou) Pharmaceuticals Co. Ltd
Centre Georges Francois Leclerc
Jules Bordet Institute
Celldex Therapeutics